Dr. Maria S. Bloomquist, MD
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Medical school
- Baylor College of Medicine (2018)
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 1,575
Licensed in Texas since 2022, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Medical school: Baylor College of Medicine
- 2018Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
TX license U0966 (first issued 2022; active) -
Dermatopathology (Pathology) Physician
TX license U0966 (first issued 2022; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Westlake Dermatology PA (54 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,575
- Services billed
- 2,817
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 739 | 548 |
| Special stained specimen slides to examine tissue, initial procedure | 85 | 76 |
| Special stained specimen slides to examine tissue, each additional procedure | 42 | 31 |
| Pathology examination of tissue using a microscope, moderately low complexity | 36 | 35 |
| Special stained specimen slides to identify organisms including interpretation and report | 34 | 26 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 7 companies reported 10 payments worth $254 in total to this clinician.
| Biofrontera Inc. | $66.55 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $58.43 |
| UCB, Inc. | $37.00 |
| Incyte Corporation | $29.87 |
| Novartis Pharmaceuticals Corporation | $22.45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.17 |
| Janssen Biotech, Inc. | $18.37 |
| Food and Beverage | $254 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.